Plain-English translation of NCT06140719 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
xPEDITE is a research study that gathers medical information from patients with diffuse midline glioma (a type of brain tumor) to create a standardized database that researchers can use. Instead of requiring you to enter data yourself, the study team collects and organizes your existing medical records—like clinic visits, hospital stays, lab results, and imaging scans—in a secure, organized way. This helps researchers understand your disease and develop better treatments more quickly.
Researchers need detailed, organized information about many patients with this rare brain tumor to understand how it develops, how different treatments work, and what outcomes patients have. By collecting real-world medical records in a standardized way, this study creates a valuable resource that can speed up the discovery of new treatments without asking patients to do extra visits or testing.
You likely qualify if…
You likely don't qualify if…
Your participation is entirely virtual and remote—you do not need to visit a clinic or hospital for this study. The research team will request your medical records from your healthcare providers and will access them electronically or via fax. The study team handles all the work of gathering, organizing, and reviewing your records; you do not need to enter any information yourself. You may be asked to complete brief surveys or questionnaires online, and the study will follow your medical information over time from your diagnosis through treatment and beyond.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States
Sponsor
xCures
Enrollment target
~400 participants
Started
November 2023
Primary completion
September 2026
Last updated on clinicaltrials.gov in April 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
xCures Study Team
xCures
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.